Evidence map›Paper›PMID 42209493›Full record

ArticleNature communications2026

Primer PICKR: literature-mined scoring platform for robust RT-qPCR primers.

Thomas G Molley, Abhinaba Banerjee, Alis Balayan, Jun K Robbins, Adam J Engler

Abstract read
In one paragraph

Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Thomas G Molley *Shu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
Abhinaba Banerjee *Shu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
Alis Balayan *Sanford Consortium for Regenerative Medicine, La Jolla, CA, USA.
Jun K RobbinsShu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA.
Adam J EnglerShu Chien-Gene Lay Department of Bioengineering, University of California, San Diego, La Jolla, CA, USA. aengler@ucsd.edu.ORCID http://orcid.org/0000-0003-1642-5380

Funding

Training Program in Basic Clinical GeneticsT32GM008666 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI HAMILTON, BRUCE A · 1998 to 2021
$8.6M
Mechanisms of vascular pathology from abnormal protein kinase G signalingR01HL132141 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI PILZ, RENATE B · 2016 to 2025
$4.5M
Mechanogenetics: An Integrated Approach to Aging in Muscle DysfunctionRF1AG045428 · NIA · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI ENGLER, ADAM J · 2025 to 2025
$1.8M
Material Stiffness Directs Oral Cancer MigrationR01CA280279 · NCI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI Adam J Engler, Marcelo Lazzaron Lamers · 2024 to 2026
$1.5M
Harnessing biophysical cues to spatially organize developing cardiac organoidsF32HL176176 · NHLBI · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI MOLLEY, THOMAS GREGORY · 2024 to 2024
$74k
NCI NIH HHS R01 CA280279NHLBI NIH HHS F32 HL176176NHLBI NIH HHS R01 HL132141NIA NIH HHS RF1 AG045428NIGMS NIH HHS T32 GM008666U.S. Department of Health & Human Services | National Institutes of Health (NIH) F32HL176176U.S. Department of Health & Human Services | National Institutes of Health (NIH) RF1AG045428U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI) R01CA280279U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (NHLBI) 2R01HL132141
6 · The paper itself

Abstract

Reliable reverse-transcription quantitative PCR (RT-qPCR) depends on well-designed primers, yet undocumented or poorly validated sequences continue to compromise reproducibility. Existing resources catalog only modest sets of empirically verified primers or generate de-novo primer pairs without experimental validation. Here, we introduce Primer PICKR (Publication Integrations for Composite Knowledge Ranking), a large-scale, open, continuously updated database that systematically converts >7,000,000 community-validated oligonucleotides from >400,000 papers into actionable design resources. PICKR aligns sequences to reference transcriptomes and assembles ranked primer pairs for over 6000 genes across ten model organisms. Composite scoring integrates citation frequency, biophysical quality, and primer-pair synergy, while experimental validation of 154 human primer pairs spanning the score distribution demonstrates near-perfect amplification success above a PICKR score of 80. By converting decades of scattered primer choices into an immediately searchable database, Primer PICKR reduces empirical screening, conserves scarce samples, and accelerates reproducible assay development.

Indexed as

DNA PrimersReverse Transcriptase Polymerase Chain ReactionAnimalsHumansReproducibility of ResultsSoftwareDNA Primers

Identifiers

PMID42209493
PMCPMC13388996

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.